News | February 10, 2026
Neuland Laboratories reports Rs 1,264.5 crore revenue for 9MFY26
The revenues this quarter are in line with the outlook we envisaged for the year
The revenues this quarter are in line with the outlook we envisaged for the year
During the quarter, the company posted Revenue from operations at Rs. 5,269 crore as compared to Rs. 4,505 crore in Q3 FY25, posting a growth of 17 per cent
The company said it voluntarily paused production at the Gagillapur plant in September 2024 for risk assessment on account of the USFDA observations
EBITDA margins expand to 31.3%
For 9 months period ended December 2023, the company’s PAT up 16% to Rs 330 crores (before exceptional items)
Dr Reddy’s Laboratories recorded revenue of Rs 6,880.20 crore during the quarter
Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders
Revenue from operations at Rs 512.81 crores registered a growth of 17% Y-o-Y for full year FY23
The business and product range of Ipca and that of Unichem complements each others business and product range
The company is one of the most profitable companies manufacturing speciality chemicals in India
Subscribe To Our Newsletter & Stay Updated
